Skip to main content
. 2018 Apr 20;9(5):502–506. doi: 10.1021/acsmedchemlett.8b00125

Table 1. Antiproliferation Activities for 26 against Nine Solid Cancer Cell Linesa.

  IC50 (nM)
compd HeLa SKOV3 A549 OVCA429 OVCA433 A2780 MDA-MB-231 MCF-7 KB
15 8826 3909 4778 5173 4389 1635 1233 3503 3691
1 62.2 47.3 45.8 41.1 130.8 20.9 85.9 445 127
2 22.9 17.3 2.0 1.7 1.1 12.7 6.0 2351 4542
3 2.8 8.3 3.7 3.9 3.3 6.6 0.8 2853 3234
4 15.4 19.2 7.9 6.1 16.3 10.2 1.1 3131 1143
5 17.8 35.8 3.3 4.4 10.1 8.7 0.5 1865 2182
6 6.9 25.0 3.5 4.0 6.6 14.5 1.4 1413 1665
cisplatin 2741 1440 13220 7296 24630 2549 NA NA NA
doxorubicin NA NA NA NA NA NA NA 879 NA
gemcitabine NA NA NA NA NA NA 36.4 NA NA
vincristine NA NA NA NA NA NA NA NA 0.65
a

MTT assay. The data are the mean of triplicate determinations. NA: not available. HeLa: human cervical cancer cell lines. SKOV3, OVCA429, OVCA433 and A2780: human ovarian cancer cell lines. A549: human nonsmall cell lung cancer cell lines. MDA-MB-231 and MCF-7: human breast cancer cell lines. KB: human oral epidermoid cancer cell lines.